van der Horst G T, Galjart N J, d'Azzo A, Galjaard H, Verheijen F W
Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands.
J Biol Chem. 1989 Jan 15;264(2):1317-22.
Lysosomal neuraminidase from human placenta has been obtained in its active form by association of an inactive neuraminidase polypeptide with beta-galactosidase and the protective protein. Using a specific antiserum, we have now identified a 66-kDa protein as the inactive neuraminidase polypeptide. It is specifically recognized on immunoblots only in its nonreduced state, and it coprecipitates with neuraminidase activity. The 66-kDa polypeptide is substantially glycosylated (38-kDa protein core with 7-14 N-linked oligosaccharide chains), a feature characteristic of lysosomal integral membrane proteins. Specific removal of the 66-kDa neuraminidase polypeptide from glycoprotein preparations prevents the generation of neuraminidase activity. Removal of beta-galactosidase or destruction of the protective protein also hinders the formation of active neuraminidase. Reconstitution of neuraminidase activity is observed after mixing glycoprotein preparations, depleted in different components of the beta-galactosidase-neuraminidase-protective protein complex, indicating that all three components of the complex are required for neuraminidase activity. Association of the neuraminidase polypeptide and the protective protein generates unstable neuraminidase activity, whereas association with beta-galactosidase is required for stability.
通过将无活性的神经氨酸酶多肽与β-半乳糖苷酶及保护蛋白结合,已获得了来自人胎盘的处于活性形式的溶酶体神经氨酸酶。利用一种特异性抗血清,我们现已鉴定出一种66 kDa的蛋白质为无活性的神经氨酸酶多肽。它仅在非还原状态下在免疫印迹上被特异性识别,并且它与神经氨酸酶活性共沉淀。该66 kDa多肽高度糖基化(具有7 - 14条N - 连接寡糖链的38 kDa蛋白核心),这是溶酶体整合膜蛋白的一个特征。从糖蛋白制剂中特异性去除66 kDa的神经氨酸酶多肽可阻止神经氨酸酶活性的产生。去除β-半乳糖苷酶或破坏保护蛋白也会阻碍活性神经氨酸酶的形成。在混合了β-半乳糖苷酶 - 神经氨酸酶 - 保护蛋白复合物不同组分缺失的糖蛋白制剂后,观察到神经氨酸酶活性的重建,这表明该复合物的所有三个组分对于神经氨酸酶活性都是必需的。神经氨酸酶多肽与保护蛋白的结合产生不稳定的神经氨酸酶活性,而与β-半乳糖苷酶的结合对于稳定性是必需的。